PedAM
Pediatric Disease Annotations & Medicines
| Disease | irritable bowel syndrome |
| Phenotype | C0021831|bowel disease |
| Sentences | 9 |
| PubMedID- 26426460 | Therapeutic options for managing irritable bowel syndrome in patients with inflammatory bowel disease includes dietary modification, interventions targeted at correction of visceral sensory dysfunction or cortical processing and modulation of the gut microbiota. |
| PubMedID- 21292684 | Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease. |
| PubMedID- 23668698 | Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. |
| PubMedID- 25580205 | Faecal calprotectin (fc), a cytosolic protein released by neutrophils (s100 family) in response to inflammation, is a simple, non-invasive test that can be used to differentiate irritable bowel syndrome (ibs) with inflammatory bowel disease (ibd), where there can be considerable symptom overlap. |
| PubMedID- 20389294 | irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation. |
| PubMedID- 23731196 | Background: gastrointestinal symptoms compatible with irritable bowel syndrome (ibs) are common in patients with inflammatory bowel disease. |
| PubMedID- 23855395 | Commentary: symptoms of irritable bowel syndrome in patients with inflammatory bowel disease--organic disease or diseased organ. |
| PubMedID- 24417262 | The nature and clinical implications of irritable bowel syndrome (ibs)-type symptoms in patients with inflammatory bowel disease (ibd) who are in apparent remission have generated considerable debate. |
| PubMedID- 25855880 | This has been used to distinguish patients exhibiting symptoms of irritable bowel syndrome from patients with inflammatory bowel disease, with a measure of success greater than with currently used techniques. |
Page: 1